Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MediWound (MDWD) EPS (Weighted Average and Diluted) (2018 - 2025)

MediWound has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$0.21 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 68.75% year-over-year to -$0.21; the TTM value through Dec 2025 reached -$0.21, up 68.75%, while the annual FY2025 figure was -$2.1, 30.69% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.21 at MediWound, up from -$10186.2 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $2937.5 in Q2 2023 and troughed at -$10186.2 in Q2 2025.
  • A 5-year average of -$1211.6 and a median of -$0.88 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 220.99% in 2023 and later plummeted 299.55% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$1.07 in 2021, then tumbled by 37.72% to -$1.47 in 2022, then soared by 88.65% to -$0.17 in 2023, then plummeted by 299.55% to -$0.67 in 2024, then skyrocketed by 68.75% to -$0.21 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for MDWD at -$0.21 in Q4 2025, -$10186.2 in Q2 2025, and -$0.67 in Q4 2024.